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Abstract
Hyperphagic obesity is characterized in part by a specific increase in meal size that contrib-
utes to increased daily energy intake, but the mechanisms underlying impaired activity of
meal size regulatory circuits, particularly those converging at the caudomedial nucleus of
the solitary tract in the hindbrain (cmNTS), remain poorly understood. In this paper, we as-
sessed the consequences of high-fat (HF) feeding and diet-induced obesity (DIO) on
cmNTS nutrient sensing and metabolic integration in the control of meal size. Mice main-
tained on a standard chow diet, low-fat (LF) diet or HF diet for 2 weeks or 6 months were im-
planted with a bilateral brain cannula targeting the cmNTS. Feeding behavior was assessed
using behavioral chambers and meal-pattern analysis following cmNTS L-leucine injections
alone or together with ip CCK. Molecular mechanisms implicated in the feeding responses
were assessed using western blot, immunofluorescence and pharmacological inhibition of
the amino acid sensing mTORC1 pathway (mammalian target of rapamycin complex 1).
We found that HF feeding blunts the anorectic consequences of cmNTS L-leucine adminis-
tration. Increased baseline activity of the L-leucine sensor P70 S6 kinase 1 and impaired
L-leucine-induced activation of this pathway in the cmNTS of HF-fed mice indicate that HF
feeding is associated with an impairment in cmNTS mTOR nutritional and hormonal sens-
ing. Interestingly, the acute orexigenic effect of the mTORC1 inhibitor rapamycin was pre-
served in HF-fed mice, supporting the assertion that HF-induced increase in baseline
cmNTS mTORC1 activity underlies the defect in L-leucine sensing. Last, the synergistic
feeding-suppressive effect of CCK and cmNTS L-leucine was abrogated in DIO mice.
These results indicate that HF feeding leads to an impairment in cmNTS nutrient sensing
and metabolic integration in the regulation of meal size.
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Introduction
Growing evidence indicates that distributed populations of specialized neurons in the brain
can detect and integrate a variety of metabolic signals, and engage downstream circuits contrib-
uting to the feedback inhibitory regulation of food intake [1]. The caudomedial nucleus of the
solitary tract (cmNTS) represents one of the key nodes of sensing and integration important to
the regulation of feeding, particularly in the direct control of meal size [2; 3]. Localized at the
interface between the periphery and higher brain structures, the cmNTS is uniquely positioned
to integrate gustatory and visceral inputs with cortico-limbic inputs, and relay the integrated
results to nearby medullary motor output circuits [4]. Increasing neuroanatomical and func-
tional evidence supports the physiological relevance of this model [3; 5–7], and one of its most
recent developments is the demonstration that the cmNTS also detects local levels of nutrients
and integrates this information with gut-derived, hormonal and forebrain descending inputs in
the control of feeding [8; 9].
Behavioral analyses of animals acutely or chronically maintained on high-energy diets indi-
cate that hyperphagia in those conditions is driven at least in part by an increase in meal size,
possibly explained by enhanced orosensory stimulation and/or reduced sensitivity to postoral
inhibitory feedback, whereas the regulation of meal frequency is relatively preserved [10; 11].
Consistent with an alteration in the processing of postoral inhibitory signals regulating meal
size, decreased responsiveness to intestinal lipids and exogenous gut peptides such as CCK or
GLP-1 has been reported in rodents fed a HF diet [12; 13] [14]. Further supporting this notion,
rodents fed a HF diet exhibit decreased intestinal expression of CCK- and GLP1-receptors, and
decreased activation of hindbrain neurons in response to gut lipid infusion [15; 16]. Together,
these data suggest a role for impaired gut-hindbrain satiation signaling in hyperphagic obesity.
However, little is known about the possible alterations in the cmNTS responses to direct nutri-
ent exposure, or in the cmNTS integrative capacity in HF-fed animals. Our previous work indi-
cates that central sensing of postprandial leucine contributes to the negative feeding inhibition
mechanisms implicated in the regulation of food intake [8; 17]. Consequently, in this study, we
tested the hypothesis that HF feeding diminishes the anorectic effects of both direct cmNTS
L-leucine sensing and the integration of cmNTS L-leucine with systemic CCK.
Materials and Methods
Animals
Experiments were performed on male C57BL/6 or POMC-EGFP mice (Jackson Laboratories,
Stock number 009593) purchased from the Jackson Laboratories. Mice were obtained between
8 and 10 weeks of age and maintained on chow, HF (D12266B, 31.8%k kcal fat, 4.4 kcal/g) or a
control low fat diet (LF, D12489B, 4.6%fat, 3.8 kcal/g) (Research Diets). All animals were
housed in individual cages and maintained in a temperature-controlled room under a standard
12h/12h light/dark cycle with ad libitum access to water and food. Before any brain injection,
animals were adapted to the brain injection system for at least 4 consecutive days preceding the
injection. All experimental protocols were approved by the Institute for Animal Studies of the
Albert Einstein College of Medicine.
CNS surgery
Surgical procedures were performed under ketamine/xylazine anesthesia. Animals were stereo-
taxically implanted with bilateral steel guide cannulae (Plastics One) positioned 2mm above
the caudomedial nucleus of the solitary tract (cannula holding bar in a 10° rostro-caudal angle,
coordinates relative to occipital suture: A/P +0.5 mm, D/V-3 mm. +/- 0.4 lateral to midline).
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Beveled stainless steel injectors (33 gauge mounted onto a 26-gauge sleeve) extending 2.0 mm
from the tip of the guide cannulas were used for injections. Animals were allowed a 1-week re-
covery. Correct bilateral NTS cannula placement was confirmed histologically postmortem.
Feeding behavior studies and injection designs
Age-matched animals were adapted for 1 week to individual feeding chambers (Med Associ-
ates) with ad libitum access to LF or HF pellets (Bioserv: 20 mg precision pellets, F05524 and
F06294). Meal patterns were determined using the following criteria: a meal was described as
the removal of five or more pellets (total mass of 0.100 g), with a maximum inter-pellet interval
of 5 min. Injections were performed in a crossover manner according to the injection designs
described below, and at least 3 days elapsed between each injection.
Injection design 1. Mice fasted for 6h received a 1 min NTS injection (50nl per side at
50 nl/min) of artificial cerebrospinal fluid (aCSF, Harvard Apparatus) alone or together with
2.1mM or 21mM L-leucine (Sigma Aldrich) 1 h before the onset of dark. Using fluorescently-
labeled leucine (Phoenix Pharmaceuticals), we confirmed that these injections targeted the
cmNTS, spreading throughout the rostrocaudal extent of the area postrema, from approxi-
mately-7.3 to-7.7 mm posterior to bregma (Paxinos and Franklin, 2001) (Fig. 1a).
Injection design 2. Mice were trained to rapidly eat a meal of their maintenance diet in
the morning after an overnight fast. On the day of the test, overnight fasted mice were refed for
1h and then received a 1 min NTS injection (50 nl per side at 50 nl/min) of DMSO alone or to-
gether with 1.25 μg rapamycin (Calbiochem).
Injection design 3. Mice fasted for 6h received (1) a 1 min NTS injection (50 nl per side at
50 nl/min) of aCSF alone or together with 2.1mM or 21 mM L-leucine followed by (2) an ip in-
jection of saline alone or with 1, 2 or 3 μg/kg BW non-sulfated CCK-8 (Bachem) 1 h before the
onset of dark.
In all designs, access to food was restored immediately after the last injection. Food intake
was continuously recorded for the following 24 h.
Immunofluorescence
Mice were anesthetized with pentobarbital and received a transcardiac perfusion of 100ml of
heparinized saline and 80 ml of 4% paraformaldehyde in KPBS. Brains were postfixed 48h in
30% sucrose 4% paraformaldehyde and sectioned using a freezing microtome. Free floating
30μm sections were blocked in 5% normal goat serum and incubated overnight at 4°C in phos-
pho-S6 ribosomal protein (Ser235/236) rabbit antibody (1:50, Cell Signaling Technology),
mouse anti-dopamine β hydroxylase (1:1000, Millipore) or mouse anti tyrosine hydroxylase
(1:100, Immunostar) in 0.3% Triton X-100 and 5% NGS. Sections were then washed and incu-
bated for 2 h with Alexa Fluor 488 or 596 secondary antibodies (Invitrogen).
Micropunch dissection
Mice were decapitated and brains were quickly dissected and rinsed in ice-cold saline. The cau-
dal brainstem section containing the NTS through the rostrocaudal extent of the area postrema
(7.3–7.7 mm caudal to bregma) was sliced, immersed in liquid nitrogen for 2s, and the dorso-
vagal complex was rapidly punched out and immediately prepared for protein extraction.
Western blot analysis
Brain micropunches were homogenized in 50mM Tris, 1 mM EGTA, 1 mM EDTA, 50 mM so-
dium fluoride, 10 mM β-glycerophosphate, 20 mM sodium pyrophosphate, 2 mM
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orthovanadate, 2mM PMSF, 1% Triton, and Complete phosphatase inhibitor cocktail (Roche).
Protein extracts (10–20 μg) were run on Criterion gels (Bio-Rad) and blotted onto nitrocellu-
lose membranes. Immunoblots were incubated in primary antibodies against phospho-p70 S6
kinase (Thr389) or p70 S6 kinase (both from Cell Signaling Technologies), followed by HRP-
linked secondary antibodies. Proteins were detected using enhanced chemiluminescence (ECL
Plus, GE Healthcare). Band intensity was determined using NIH Image J software.
Statistical analysis
All data, presented as means ± SEM, were analyzed using GraphPad Prism 5. For all statistical
tests, an α risk of 5% was used. Multiple comparisons were tested with one-way or two-way
ANOVAs for repeated measures and adjusted with Bonferroni post-tests. Single comparisons
were made using one-tail Student t tests.
Results
cmNTS L-leucine administration reduces food intake in mice
We first assessed the behavioral and metabolic consequences of cmNTS L-leucine sensing in 10-
week-old mice maintained on a regular chow diet. We used a dose of 105 pmol/side L-leucine
(or 50nl per side of 2.1 mmol/L). This dose is consistent with the postprandial increase in hypo-
thalamic parenchymal L-leucine concentration measured in rodents in response to the ingestion
of a high-protein meal in microdialysis studies [18–20]. L-leucine in the CSF may be taken up by
neurons via L-type amino acid transporter 1 (LAT1) [21] which is ubiquitously expressed in
brain microvessels and circumventricular organs [22]. Administration of L-leucine into the
cmNTS of 6h-fasted mice robustly reduced food intake and 24h body weight gain (Fig. 1b and
1c). The reduction of food intake occurred rapidly after the injection, as evidenced by the lower
first meal size and first meal latency following the L-leucine injection compared to the vehicle in-
jection (Fig. 1d and 1e). Lower food intake in L-leucine treated animals was maintained
Fig 1. cmNTS L-leucine reduces food intake and body weight gain in chow fedmice. (a) cmNTS distribution of fluorescent-labeled L-leucine following a
cmNTS targeted injection with inverted colors. ap: area postrema, cc: central canal, DMX: vagus nerve X. (b) Food intake, (c) 24h body weight change, (d)
first meal size, (e) first meal latency, (f) meal size and (g) meal number 6h fasted mice following a cmNTS injection of L-leucine or vehicle. n = 10–12, *:
P<0.05, **: P<0.01
doi:10.1371/journal.pone.0118888.g001
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throughout the 24h following the injection, owing to a decrease in meal size for the first 2h fol-
lowing the injection (Fig. 1f), and a decrease in meal frequency starting 2h after the brain injec-
tion (Fig. 1g). Importantly, previous studies indicate that intracerebroventrivular L-leucine fails
to induce the formation of conditioned taste aversion [23]. In vehicle-injected controls, the
amount of calories ingested 1h to 24h after the cmNTS injection are in the range of previously
reported values in mice [17; 24], supporting the conclusion that the injection procedure did not
induce a non-specific aversive response to NTS or AP (area postrema) activation.
HF feeding attenuates the anorectic effects of cmNTS L-Leucine
To test the consequences of DIO on cmNTS L-Leucine sensing, we measured the feeding re-
sponse to cmNTS L-leucine administration in mice fed a HF diet or a LF control diet for
6 months from weaning, using a similar paradigm as that used in young mice. HF-fed mice
consumed more calories over 24h (average 24h calorie intake over the 5 days preceding the
first brain injection: 17.8±2.5 vs. 24.5±1.8 kCal, p = 0.02 in LF vs. HF-fed mice), were signifi-
cantly heavier (body weight after surgical recovery: 30.68 ± 1.69 g vs. 38.45 ± 5.18 g in LFD vs
DIO mice, p<0.001) and had an increased fat mass (fat mass after surgical recovery: 16.2 ± 1.6
g vs. 5.16 ± 0.5 g in LF vs DIO mice, p<0.001) compared to LF-fed controls. In age-matched
LF-fed mice, bilateral cmNTS administration of 105 pmol per side L-leucine produced an ano-
rectic response similar to that measured in young LF-fed mice (Fig. 2a). In contrast, the same
dose of L-leucine failed to suppress food intake in DIO mice (Fig. 2b).
We then assessed the feeding response to a bilateral injection of a 10 times higher dose of
L-leucine (1050 pmol/side) injected into the cmNTS in DIO mice. In age-matched LF-fed mice,
bilateral cmNTS administration of 1050 pmol per side L-leucine produced an anorectic re-
sponse similar to that measured in young LF-fed mice (Fig. 2c). In DIO mice, this dose of L-leu-
cine acutely suppressed food intake, as evidenced by the reduced first meal size and 1h food
intake (Fig. 2d), but 24h food intake and 24h body weight change remained the same as follow-
ing vehicle administration (Fig. 2d). In addition, first meal latency (4.51±1.49 min vs. 5.65±2.77
min, p = 0.36 following aCSF or L-leucine treatment) and meal frequency (Fig. 2d) were not sig-
nificantly altered following the 1050 pmol/side L-leucine injection into the cmNTS.
To determine whether the lack of response to cmNTS L-leucine measured in DIO mice was
a consequence of their chronic exposure to HF feeding and increased adiposity, or a dysfunc-
tion occurring early during the development of DIO, we tested the feeding response to cmNTS
L-leucine in mice fed a HF diet for 2 weeks beginning at 8 weeks of age. Two weeks of HF feed-
ing did not significantly alter body weight or adiposity (starting body weight: 22.6 ± 0.5 vs. 22.6
± 0.8 g, body weight after 2 weeks: 24.2± 0.6 vs. 25.2 ± 0.7 in LF vs HF-fed mice, p = 0.18, n =
6). In age-matched LF-fed mice, bilateral cmNTS administration of 105 pmol per side L-leu-
cine produced an anorectic response similar to that measured in chow-fed mice (Fig. 2e). Injec-
tion of 105 pmol/side L-leucine into the cmNTS of mice fed a HF diet for 2 weeks did not
reduce first meal size and did not suppress 1h and 2h food intake (Fig. 2f) and did not change
first meal latency (data not shown). Long-term anorectic consequences of cmNTS leucine were
attenuated in this group (differences at 12h and 24h not statistically different). However, the
comparison of the feeding kinetics following aCSF or leucine treatment indicates that leucine
produced a significant overall change in feeding in mice fed a HF-diet for 2 weeks (overall ef-
fect of the injection p = 0.038 in repeated measures 2-way ANOVA testing) (Fig. 2f). Meal pat-
tern analysis indicate that decreased food intake following cmNTS L-leucine administration
was a consequence of reduced meal frequency (Fig. 2f), with no change in meal size (Fig. 2f).
Together, these data indicate that 2-week HF-feeding attenuates the acute anorectic conse-
quences of cmNTS leucine administration.
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Fig 2. Impaired anorectic effect of cmNTs L-leucine in HF-fed and diet-induced obesemice. 24h food
intake, meal size, meal number and first meal size following a cmNTS injection of aCSF or L-leucine
105pmol/side in mice fed a LF- or HF-diet for 6 months (a, b), 1050pmol/side in mice fed a LF- or HF-diet for 6
months (c,d), or 105pmol/side in mice fed a LF- or HF-diet for 2 weeks (e,f). N = 5–6, *: P<0.05. **: P<0.01
doi:10.1371/journal.pone.0118888.g002
Nutrient Sensing and High-Fat Feeding
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DIO impairs cmNTSmTORC1 /p70 S6 kinase 1 signaling
Activation of the amino acid sensing mTORC1/p70 S6 kinase 1 pathway following central
intracerebroventricular or hypothalamic parenchymal L-leucine administration has been pre-
viously implicated in the anorectic effect of central L-leucine [17; 23], as well as in the anorectic
effect of cmNTS L-leucine in rats [8]. To confirm that this pathway is also responsive to local
cmNTS L-leucine injection in mice, we measured the expression of the activated phosphorylat-
ed form of p70 S6 kinase 1, a downstream effector of mTORC1, in dorsovagal complex (DVC)
micropunches collected 30 min after a cmNTS injection of a feeding inhibitory dose of L-leu-
cine or aCSF. cmNTS L-leucine injection significantly increased p70 S6 kinase 1 phosphoryla-
tion compared to aCSF injection (Fig. 3a) in mice fed a LFD. In contrast, in mice fed a HF diet
for 2 weeks, cmNTS L-leucine failed to increase DVC P70 S6 kinase 1 phosphorylation
(Fig. 3a). Interestingly, these blots (all samples were processed together on the same blot) indi-
cate that after aCSF administration, P70 S6 kinase 1 activity tended to be higher in HF-fed
mice than in LFD controls (P = 0.08), suggesting that baseline activity of the mTORC1/p70 S6
kinase 1 pathway is increased in the cmNTS following 2 weeks of HF feeding. This was con-
firmed by evaluating basal levels of phosphorylated ribosomal protein S6 (p-rpS6), a down-
stream effector of mTORC1 and p70 S6 kinase 1 in fasted uninjected animals. In fasted LF-fed
controls, p-rpS6 was absent from the cmNTS (Fig. 3b), whereas p-rpS6 was expressed in the
cmNTS of fasted HF-fed mice (Fig. 3c). Immunofluorescent colocalization of p-rpS6 with
POMC (using POMC-GFP mice), tyrosine hydroxylase (TH) or dopamine beta-hydroxylase
(DBH) in cmNTS brain sections of fasted HF-fed mice indicated that some cmNTS cells ex-
pressing p-rpS6 also expressed POMC (Fig. 3d) or TH (Fig. 3e). However, we failed to observe
colocalization of DBH with prpS6 (Fig. 3f).
Inhibition of cmNTSmTORC1 signaling promotes feeding in DIO mice
We previously found that cmNTS application of the mTORC1 inhibitor rapamycin promotes
feeding in chow fed rats [8]. To test whether the orexigenic response to mTORC1 inhibition is
preserved in DIO mice, we measured the feeding consequences of local cmNTS rapamycin in-
jection in presated DIO mice or LF-fed controls. In mice maintained on LF, rapamycin rapidly
induced feeding, as evidenced by a significant decrease in first meal latency and a significant in-
crease in first meal size (Fig. 3g). Increased food intake in rapamycin treated mice was main-
tained for 6h following the injection (Fig. 3g) due to an increase in meal size, with no change in
meal frequency (data not shown). In DIO mice, the orexigenic response to rapamycin was
maintained, albeit at a reduced level. First meal size was significantly increased and first meal
latency was significantly decreased following cmNTS rapamycin administration compared to
vehicle (Fig. 3h). However, the rapamycin-induced hyperphagia was not sustained in DIO
mice, and cumulative food intakes were not significantly different following rapamycin and ve-
hicle treatment beginning 2h after the brain injections.
HF feeding impairs cmNTS integration of meal-related signals
Our previous work supports the idea that the cmNTS integrates information arising from cir-
culating nutrients and gut-derived signals to regulate meal size [8]. To test the hypothesis that
DIO impairs the ability of the cmNTS to integrate signals arising from circulating nutrients
with the gut satiety peptide CCK, we first identified a subthreshold dose of ip CCK that had no
significant anorectic effect in mice fed a LF or HF-diet for 6 months (Fig. 4a). We then com-
bined a cmNTS injection of an anorectic dose of L-leucine (105 pmol/side in LF- fed mice,
1.05nmol/side in HF-fed mice) or vehicle with a subthreshold dose of ip CCK (1 μg/kg in con-
trols, and 2 μg/kg in HF-fed mice) or vehicle. In controls, we confirmed that the combination
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Fig 3. Impaired activity of the cmNTS p70 S6 kinase 1 pathway in HF-fed mice. p70 S6 kinase 1 Thr389
phosphorylation in the cmNTS of (a) chow-fed mice or HF-fed mice (n = 5–6). Distribution of phosphorylated
S6 ribosomal protein in the cmNTS of 6h-fasted (b) chow-fed mice or (c) HF diet-fed mice. Colocalization
(right, orange) or phosphorylated ribosomal protein S6 (p-rpS6, middle, red) and POMC (d), TH (e) or DBH (f)
(left, green) in the cmNTS of 6h-fasted HF-fed mice. Scale bar: 50 μm. First meal size, first meal latency and
Nutrient Sensing and High-Fat Feeding
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of ip CCK and cmNTS leucine produced a synergistic suppression of food intake (Fig. 4b).
Mice receiving both the ip injection of CCK and the cmNTS injection of L-leucine had a 25%
further reduction in food intake compared to mice that received L-leucine alone. In contrast, a
subthreshold dose of ip CCK did not modify the reduction of food intake induced by an ano-
rectic dose of cmNTS L-leucine in HF-fed mice (Fig. 4c).
Discussion
Hyperphagic obesity is characterized by an increase in meal size that contributes to increased
daily energy intake [11]. The cmNTS is a key region implicated in the regulation of meal size
through its processing of post-ingestive neural inputs arising from vagal afferents and descend-
ing cortico-limbic inputs, as well as inputs deriving from the local brainstem detection of circu-
lating nutritional and hormonal signals of fuel availability. As little is known about the
consequences of HF feeding on cmNTS nutrient sensing and integrative functions in the con-
trol of feeding, we characterized the behavioral and metabolic consequences of cmNTS L-leu-
cine detection in HF-fed and DIO mice, we investigated the consequences of HF feeding on
cmNTS metabolic integration, and we identified mechanisms implicated in the changes in
cmNTS nutrient sensing in HF-fed non-obese and obese mice.
Our results extend our previous report [8] supporting a role for the cmNTS as a nutrient-
sensing region engaged in the feedback inhibitory regulation of feeding and the integration of
multiple metabolic signals, and indicate that this regulation is conserved in mice and rats. Our
results also identify in mice maintained on a LF diet that cmNTS L-leucine sensing reduces
feeding through multiple behavioral changes, both acutely through an increase in meal latency
and a decrease in meal size, and over the longer term through a decrease in meal number.
Here we show for the first time that DIO in mice is associated with a desensitization to the
anorectic effect of local cmNTS L-leucine administration. Interestingly, increasing the leucine
dose restored the ability of leucine to reduce acute food intake in HF-fed DIO mice, but failed
to restore the longer term suppression of feeding across the ensuing 24 hours. In contrast, in
food intake in LF-fed (g, n = 5) or HF-fed (h, n = 5) pre-sated mice following a cmNTS injected of rapamycin or
vehicle. *: P<0.05.
doi:10.1371/journal.pone.0118888.g003
Fig 4. Impaired cmNTSmetabolic integration in DIOmice. (a) 30 min food intake in chow-fed or HF-fed mice following ip injection of different doses of
CCK. 30 min food intake following the combination of an anorectic dose of L-leucine injected into the cmNTS together with a subthreshold ip CCK dose in (b)
chow-fed mice (leucine: 105pmol/side, CCK: 1 μg/kg) or (c) high-fat fed (leucine: 1.05nmol/side, CCK: 2 μg/kg) mice. n = 5–6, *: P<0.05, **: P<0.01
doi:10.1371/journal.pone.0118888.g004
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non-obese mice fed a HF diet for only 2 weeks, cmNTS L-leucine failed to acutely suppress
feeding but significantly reduced 24h food intake. These observations demonstrate that the
acute feeding-suppressive effects of cmNTS L-leucine administration are impaired early during
the development of DIO, independently of adiposity, and suggest that the impairment in the
long term feeding suppressive effects of cmNTS L-leucine is not a primary consequence of high
fat feeding, but instead is related to increased adiposity, possibly via elevated leptin levels.
To further characterize the consequences of short term high fat feeding on the acute regula-
tion of meal size in response to acute cmNTS nutrient application, we assessed the caudal
brainstem DVC activity of the amino-acid sensing mTORC1 pathway. Our results suggest a
role for constitutive activation of cmNTS mTORC1 signaling in the lack of acute feeding re-
sponse to cmNTS L-leucine in HF-fed mice. This conclusion is supported by the higher base-
line activity level of the mTORC1 effector p70 S6 kinase 1 in the cmNTS of HF-fed mice
compared to chow fed controls. Increased baseline mTORC1 activity as a consequence of HF
feeding has been consistently reported in several tissues including the liver, adipose tissue,
muscle and hippocampus [25–27], but this result contrasts with a study reporting that HF feed-
ing reduced mTORC1 signaling in the hypothalamus [28]. Interestingly, several reports indi-
cate that the activity of nutrient-sensing signaling pathways implicated in the central control of
energy metabolism, such as the AMPK or Sirt1 signaling pathways, is altered in response to HF
feeding and DIO [29–31]. The lack of L-leucine—induced increase in p70 S6 kinase 1 activity
in mice maintained on HF diet for 2 weeks provides further evidence in favor of impaired
cmNTS mTORC1 signaling as a mechanism underlying the lack of acute anorectic response to
cmNTS L-leucine. Thus, we speculate that hyperphagia in HF-fed mice is at least in part medi-
ated by a chronic elevation in cmNTS mTORC1 activity that reduces the dynamic range of
mTOR activation in these neurons, effectively making them less sensitive to normal feedback
stimulation. Consistent with this hypothesis, the orexigenic response to pharmacological
cmNTS mTORC1 inhibition is preserved in HF-fed mice. Thus, reduction in cmNTS
mTORC1 tone, through rapamycin treatment or caloric restriction, might be predicted to re-
store the dynamic range of cmNTS leucine-induced mTORC1 signaling important in the nega-
tive feedback the control of ingestion.
The fact that cmNTS rapamycin was able to rapidly stimulate feeding in both LF and DIO
animals suggests: 1) a strong constitutive feeding inhibitory circuitry operating at the level of
the cmNTS, and 2) that acute mTORC1 inhibition in the cmNTS produces an acute change in
local neuronal polarization state and a consequent alteration in feeding modulatory peptide
signaling. These suggestions raise the important mechanistic questions of which NTS neuro-
transmitter and/or neuropeptide signals may keep feeding at bay. Further studies are needed to
confirm the role of melanocortinergic and catecholaminergic circuits in the ability of brainstem
rapamycin to regulate meal size.
Last, we examined the short term feeding consequences of combinations of local nutrient
infusions of leucine and peripheral administration of the gut satiety peptide CCK. We found,
as in rats, that this combination of nutrient stimulation and gut satiety peptide produces a
greater inhibition of acute food intake and meal size than either stimulus alone. However, in
DIO mice, the combination of a subthreshold dose of ip CCK with an anorectic dose of L-leu-
cine failed to produce a synergistic suppression of food intake. These data demonstrate that
cmNTS mechanisms of metabolic integration are impaired in DIO.
Thus, this study identified two novel mechanisms through which the post-ingestive regula-
tion of meal size is impaired in HF feeding: 1) a desensitization to the anorectic effect of amino
acid nutrient stimuli at the level of the cmNTS, and 2) an impairment in the mechanisms
through which various metabolic signals synergistically interact to control feeding. The intra-
cellular signaling cascades mediating synergistic feeding inhibitory interactions between
Nutrient Sensing and High-Fat Feeding
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brainstem nutrient and gut peptide stimuli, and how they are altered during DIO, remain to be
determined. Future characterization of these mechanisms will likely provide novel targets for
effective combination therapies in the treatment of obesity.
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